New treatment for life-threatening bacterial diseases

Researchers has identified a new treatment against antibiotic resistant bacterial infections. This could prevent unnecessary deaths from diseases such as pneumonia and sepsis. The treatment is a valuable alternative to current medications, particularly for infections that have become resistant to antibiotics. The bacterial toxins, produced by major human pathogens such as Streptococcus pneumonia,Streptococcus pyogenes and Methicillin Resistant Staphlycoccus aureus (MRSA) were neutralised as they bound to the liposomes instead of human cells. Liposomes are already licensed for medical use as carriers for drug delivery and are nontoxic to humans.